UBS lowers Zscaler stock price target to $340 on mixed growth outlook

Published 26/11/2025, 15:58
UBS lowers Zscaler stock price target to $340 on mixed growth outlook

Investing.com - UBS lowered its price target on Zscaler (NASDAQ:ZS) to $340 from $350 while maintaining a Buy rating on Wednesday. This target remains significantly above the current stock price of $257.01 and aligns with the broader analyst consensus, which remains bullish with an average recommendation of 1.61 (Buy).

The cybersecurity firm’s first-quarter results showed organic net new annual recurring revenue (NNARR) growth accelerating to what UBS estimates was over 20%, exceeding internal expectations despite the lack of direct organic ARR disclosure. This performance is consistent with Zscaler’s impressive 23.31% year-over-year revenue growth.

UBS noted that this strong NNARR performance contributed to the majority of Zscaler’s $22 million increase to its full-year ARR guidance, with its Red Canary acquisition also outperforming expectations.

The outlook for the remainder of the year suggests approximately 10% organic NNARR growth, reflecting continued business momentum for the cybersecurity provider.

UBS maintains that Zscaler shares remain attractive at 11 times enterprise value to sales (EV/S) for a company delivering 22% year-over-year growth.

In other recent news, Zscaler reported its first-quarter fiscal 2026 results, showing a 26% year-over-year growth in annual recurring revenue (ARR) to $3,204 million, surpassing consensus estimates by $22 million. The company also exceeded FactSet consensus estimates in revenue, billings, earnings per share, and free cash flow, prompting Zscaler to raise its full-year fiscal 2026 guidance across all financial metrics. However, several analyst firms have adjusted their price targets for Zscaler. Needham lowered its target to $310 while maintaining a Buy rating, citing ARR concerns. Similarly, Mizuho reduced its price target to $310, maintaining a Neutral rating due to acquisition clarity concerns. Scotiabank also lowered its target to $320, describing the company’s bottom-line results as slightly underwhelming despite decent ARR performance. Stifel adjusted its price target to $320, maintaining a Buy rating, although the reason for the change was not explicitly connected to Zscaler’s performance. Meanwhile, Cantor Fitzgerald reiterated its Overweight rating with a $365 price target, reflecting confidence in the company’s financial outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.